A Director at Cambrex Corp (CBM) is Selling Shares


Yesterday, a Director at Cambrex Corp (NYSE: CBM), Ilan Kaufthal, sold shares of CBM for $343.1K.

Following Ilan Kaufthal’s last CBM Sell transaction on December 01, 2015, the stock climbed by 10.8%. In addition to Ilan Kaufthal, 6 other CBM executives reported Sell trades in the last month.

See today’s analyst top recommended stocks >>

Based on Cambrex Corp’s latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $152 million and quarterly net profit of $40.42 million. In comparison, last year the company earned revenue of $135 million and had a net profit of $25.03 million. CBM’s market cap is $2.12B and the company has a P/E ratio of 17.51. Currently, Cambrex Corp has an average volume of 316.7K.

In the last 30 days, insiders have sold $9.95M worth of CBM shares and purchased $3.3M worth of CBM shares. The insider sentiment on Cambrex Corp has been neutral according to 31 insider trades in the past three months. This sentiment is slightly higher than the average sentiment of company insiders in this sector.

Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Cambrex Corp. engages in the provision of products, services, and technologies to accelerate and improve the development and commercialization of new and generic therapeutics. It supplies to innovator and generic pharmaceutical companies.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts